Cancer Home > Zevalin
Clinical Effects of ZevalinIn clinical trials, Zevalin has been shown to decrease the risk of disease progression in people with non-Hodgkin's lymphoma. In these studies, people who received Zevalin after responding to first-line chemotherapy had a 54 percent decreased risk of their cancer progressing further, compared to people who did not receive any additional treatment.
When and How to Receive ItSome general considerations to keep in mind during treatment with Zevalin include the following:
- This medication comes as a liquid that is given as an injection into a vein (an intravenous, or IV, injection) over a 10-minute period.
- Zevalin is part of a treatment regimen that includes rituximab. It is normally given as a single dose within four hours after receiving a second dose of rituximab.
- The injection will be given by a healthcare provider in a healthcare setting, such as a hospital or clinic.
- You will be given other medications by mouth before your dose of rituximab. This usually consists of acetaminophen (Tylenol®) and diphenhydramine (Benadryl® and others).
- For the medication to work properly, it must be used as prescribed. It is important to keep your appointment to receive your Zevalin dose.